M&A Healthcare Advisors (MAHA) Exclusively Represents Hoover Pharmacy in their Sale to CVS

Healthcare Advisors

LOS ANGELES, March 28, 2023 /PRNewswire/ — M&A Healthcare Advisors (MAHA), a boutique merger and acquisition (M&A) advisory group, is proud to announce the sale of Hoover Pharmacy, a Specialty & Retail Pharmacy based in the San Francisco Bay area focused on serving Stanford Medical Campus patients. Hoover Pharmacy’s files were acquired by CVS and all patients will now receive dispensing service at their local Palo Alto branch.

“Andre and his team were instrumental in driving value for our pharmacy and securing the ideal buyer to meet our specific sale criteria. His reliable and consistent guidance allowed us to focus on maintaining operations throughout the transaction while introducing a buyer that would faithfully continue our legacy of care with our patients across the bay area”, Jonathan Han, COO of Hoover Pharmacy.

While there is currently a sense of uncertainty in the larger economy, healthcare M&A remains active with the successful acquisition of Hoover being another great example of the resiliency of lower-middle market healthcare. The team at M&A Healthcare Advisors provided attentive and expert guidance, allowing the Hoover ownership team to achieve their unique sale goals on the identified timeline.

“We are very proud of the level of service we provide to our clients and the successful and efficient sale of Hoover Pharmacy speaks to the client-centric focus we strive for as an organization. Andre’s contributions and representation of the Hoover ownership team was commendable and demonstrates our belief that having an experienced and dedicated sell side advisor greatly increases the probability of achieving a successful outcome”, say Co-Founders Mark Thomas & Mike Moran.

This sale continues the tradition of excellence put in place by M&A Healthcare Advisors.
About M&A Healthcare Advisors

M&A Healthcare Advisors (MAHA), is a boutique merger and acquisition (M&A) advisory group, focused on the lower-middle market healthcare industry. Their core purpose is to provide comprehensive, efficient, and committed transactional support for emerging or established, lower-middle market healthcare businesses.

The team at M&A Healthcare Advisors has sold companies in a variety of healthcare segments: Behavioral Health, Autism Services, I/DD, Hospice, Home Health, Home Care, Private Duty, Physical Therapy, Staffing/Medical Recruiting, Facility-Based Care, Not-for-Profits, and all types of Pharmacy. Their full suite of services includes Sell-Side Representation, M&A Hourly Consulting, and Expert Valuation services.

Business Contact
Mark Thomas
Partner, Director of Operations
M&A Healthcare Advisors
mthomas@mahealthcareadvisors.com

Follow us on social media for the latest updates in B2B!

Image

Latest

personal branding
Personal Branding Now Drives B2B Success, Customer Trust, and Competitive Advantage
December 5, 2025

Personal branding has rapidly shifted from a “nice-to-have” to a strategic imperative in B2B marketing, reshaping how companies communicate, differentiate, and build trust. As industries evolve and professionals take on more dynamic, multi-stream careers, visibility and authenticity have become critical assets. Key findings from the Edelman + LinkedIn Thought Leadership Impact Report show that…

Read More
IT
Real-World IT Practices Are Streamlining AV Deployments and Raising the Bar for Consistency
December 4, 2025

For years, the AV industry has discussed the long-anticipated convergence with IT—but that shift is no longer theoretical. With cloud adoption accelerating, hybrid work normalizing, and organizations rebuilding digital infrastructure after years of rapid change, AV systems now sit squarely on the IT backbone. In fact, the majority of newly upgraded conference rooms require network-centric…

Read More
ROI
ROI Case Study
December 3, 2025

Denials are no longer a slow leak in the revenue cycle—they’re a fast-moving, rule-shifting game controlled by payers, and hospitals that don’t model denial patterns in real time end up budgeting around losses they could have prevented. PayerWatch’s four-digit, client-verified ROI in 2024 shows what happens when a hospital stops reacting claim by…

Read More
coverage
Clip 2 – Fighting for Coverage: One Patient’s Story
December 3, 2025

Health insurers love to advertise themselves as guardians of care, but the real story often begins when a patient’s life no longer fits neatly into a spreadsheet. In oncology especially, “coverage” isn’t a bureaucratic checkbox—it’s the fragile bridge between a treatment that finally works and a relapse that can undo years of grit…

Read More